- Report
- November 2023
- 178 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- November 2023
- 182 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- October 2023
- 181 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- June 2023
- 113 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- April 2023
- 113 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- November 2022
- 111 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- October 2023
- 90 Pages
United States
From €3458EUR$3,500USD£2,878GBP
- Drug Pipelines
- August 2022
- 75 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Report
- January 2022
- 88 Pages
Global
From €5187EUR$5,250USD£4,318GBP
€7411EUR$7,500USD£6,168GBP
- Report
- January 2022
- 200 Pages
Global
From €5187EUR$5,250USD£4,318GBP
€7411EUR$7,500USD£6,168GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 200 Pages
Global
From €5187EUR$5,250USD£4,318GBP
€7411EUR$7,500USD£6,168GBP
- Clinical Trials
- January 2021
- 60 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Report
- May 2022
- 38 Pages
Global
From €1976EUR$2,000USD£1,645GBP
- Report
- October 2023
- 167 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- November 2023
- 163 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- November 2023
- 152 Pages
United States
From €2470EUR$2,500USD£2,056GBP
- Report
- March 2023
- 161 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- May 2023
- 147 Pages
Global
From €5927EUR$5,999USD£4,934GBP
The Sexual and Reproductive Health Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and treatments related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, erectile dysfunction, and contraception. They also include treatments for sexually transmitted infections, such as HIV and HPV.
The market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include Pfizer, Merck, Bayer, and GSK. These companies are involved in the research and development of new drugs and treatments, as well as the marketing and distribution of existing products. Other companies in the market include Allergan, Teva, and Mylan. Show Less Read more